India’s Cheap Weight-Loss Drugs Get A Reality Check
Bloomberg Television · 1:34
Despite patent expiry making GLP-1s like Ozempic and Wegovy available as generics for as little as $14 a month, Indian uptake has lagged bullish forecasts. Price is only one barrier: doctor hesitation, obesity’s weak...